Tumour-Associated Trypsin Inhibitor TATI Is a Prognostic Marker in Colorectal Cancer

Publisher： Karger

E-ISSN： 1423-0232|82|4|234-241

ISSN： 0030-2414

Source： Oncology, Vol.82, Iss.4, 2012-04, pp. : 234-241

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Colorectal Cancer Relapse: Allelic Alterations Associated with Tumour Marker Overexpression

By  

Oncology, Vol. 65, Iss. 2, 2003-08 ,pp. : 146-151

Karger

Access to resources Recommend Favorite

Trypsinogen-1, -2 and tumour-associated trypsin-inhibitor in bile and biliary tract tissues from patients with biliary tract diseases and pancreatic carcinomas

By Hedström J.   Haglund C.   Leinonen J.   Nordling S.   Stenman U.-H.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 61, Iss. 2, 2001-04 ,pp. : 111-118

Informa Healthcare

Access to resources Recommend Favorite

Overexpression of Tumor-Associated Trypsin Inhibitor (SPINK1/TATI) in Hepatitis C-Associated Hepatocellular Carcinoma: Potential Implications for Viral Hepatocarcinogenesis

By  

Oncology Research and Treatment, Vol. 37, Iss. 12, 2014-11 ,pp. : 732-738

Karger

Access to resources Recommend Favorite

Dendritic Cells Transfected with a DNA Construct Encoding Tumour‐associated Antigen Epitopes Induce a Cytotoxic Immune Response Against Autologous Tumour Cells in a Culture of Mononuclear Cells from Colorectal Cancer Patients

By  

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (ELECTRONIC), Vol. 82, Iss. 2, 2015-08 ,pp. : 110-117

John Wiley & Sons Inc

Access to resources Recommend Favorite

Preoperative Serum Alpha-L-Fucosidase Activity as a Prognostic Marker in Colorectal Cancer

By  

Oncology, Vol. 64, Iss. 1, 2002-12 ,pp. : 36-45

Karger

Access to resources Recommend Favorite